These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8511599)

  • 1. Monoclonal antibodies in ovarian and prostate cancer.
    Neal CE; Swenson LC; Fanning J; Texter JH
    Semin Nucl Med; 1993 Apr; 23(2):114-26. PubMed ID: 8511599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoscintigraphy in patients with colorectal, ovarian, and prostate cancer. Results with site-specific immunoconjugates.
    Maguire RT; Pascucci VL; Maroli AN; Gulfo JV
    Cancer; 1993 Dec; 72(11 Suppl):3453-62. PubMed ID: 8242578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlative imaging with monoclonal antibodies in colorectal, ovarian, and prostate cancer.
    Neal CE; Meis LC
    Semin Nucl Med; 1994 Oct; 24(4):272-85. PubMed ID: 7817200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of radioimmunoscintigraphy and computed tomography scan prior to reassessment laparotomy of patients with ovarian carcinoma. A preliminary report.
    Method MW; Serafini AN; Averette HE; Rodriguez M; Penalver MA; Sevin BU
    Cancer; 1996 Jun; 77(11):2286-93. PubMed ID: 8635097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter radioimmunoscintigraphic evaluation of patients with prostate carcinoma using indium-111 capromab pendetide.
    Hinkle GH; Burgers JK; Neal CE; Texter JH; Kahn D; Williams RD; Maguire R; Rogers B; Olsen JO; Badalament RA
    Cancer; 1998 Aug; 83(4):739-47. PubMed ID: 9708939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indium-111 satumomab pendetide: the first FDA-approved monoclonal antibody for tumor imaging.
    Bohdiewicz PJ
    J Nucl Med Technol; 1998 Sep; 26(3):155-63; quiz 170-1. PubMed ID: 9755434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumour detection and localization using 99Tcm-labelled OV-TL 3 Fab' in patients suspected of ovarian cancer.
    Tibben JG; Massuger LF; Claessens RA; Schijf CP; Pak KY; Strijk SP; Kenemans P; Corstens FH
    Nucl Med Commun; 1992 Dec; 13(12):885-93. PubMed ID: 1465272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of indium-111 radioimmunoscintigraphy in post-radical retropubic prostatectomy management of prostate cancer patients.
    Jani AB; Liauw SL; Blend MJ
    Clin Med Res; 2007 Jun; 5(2):123-31. PubMed ID: 17607048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging prostate cancer with technetium-99m-7E11-C5.3 (CYT-351).
    Chengazi VU; Feneley MR; Ellison D; Stalteri M; Granowski A; Granowska M; Nimmon CC; Mather SJ; Kirby RS; Britton KE
    J Nucl Med; 1997 May; 38(5):675-82. PubMed ID: 9170426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate cancer imaging with a new monoclonal antibody: a preliminary report.
    Sanford E; Grzonka R; Heal A; Helal M; Persky L; Tyson I
    Ann Surg Oncol; 1994 Sep; 1(5):400-4. PubMed ID: 7850541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of radioimmunoscintigraphy on the management of colorectal and ovarian cancer patients: a retrospective study.
    Blend MJ; Bhadkamkar VA
    Cancer Invest; 1998; 16(7):431-41. PubMed ID: 9774949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioimmunoscintigraphy in patients with ovarian cancer.
    Kalofonos HP; Karamouzis MV; Epenetos AA
    Acta Oncol; 2001; 40(5):549-57. PubMed ID: 11669325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A thousand points of light or just dim bulbs? Radiolabeled antibodies and colorectal cancer imaging.
    Moffat FL; Gulec SA; Serafini AN; Sfakianakis GN; Pop R; Robinson DS; Franceschi D; Boggs J; Livingstone AS
    Cancer Invest; 1999; 17(5):322-34. PubMed ID: 10370360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-111 CYT-103 immunoscintigraphy in the imaging of ovarian carcinoma.
    Neal CE; Baker MR; Hilgers RD; Fanning J; Burke RC; Snodgrass J; Cull RD
    Clin Nucl Med; 1993 Jun; 18(6):472-6. PubMed ID: 8319398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic value of single-photon emission computed tomography/computed tomography fusion to radioimmunoscintigraphic imaging of prostate cancer.
    Sodee DB; Sodee AE; Bakale G
    Semin Nucl Med; 2007 Jan; 37(1):17-28. PubMed ID: 17161036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic evaluation of 111In and 99mTc radiolabelled monoclonal antibodies in ovarian and colorectal cancer: correlations with surgery.
    Granowska M; Mather SJ; Britton KE
    Int J Rad Appl Instrum B; 1991; 18(4):413-24. PubMed ID: 1864730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection and localization of ovarian cancer with radiolabeled monoclonal antibodies.
    Massuger LF; Kenemans P; Claessens RA; Verheijen RH; Corstens FH
    Eur J Obstet Gynecol Reprod Biol; 1991 Aug; 41(1):47-63. PubMed ID: 1748227
    [No Abstract]   [Full Text] [Related]  

  • 18. Radioimmunodetection of ovarian cancer.
    Ahlström KR; Hietala SO; Stendahl U; Stigbrand T
    Acta Oncol; 1993; 32(7-8):729-34. PubMed ID: 8305219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioimmunodetection of prostate cancer by 111In-labeled monoclonal antibody against prostatic acid phosphatase.
    Ahonen A; Kairemo K; Karnani P; Heikkilä J; Nurmi M; Teräs M; Lukkarinen O
    Acta Oncol; 1993; 32(7-8):723-7. PubMed ID: 8305218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.